Your browser doesn't support javascript.
loading
Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.
McLaughlin, Milena M; Miglis, Cristina; Skoglund, Erik; Wagner, Jamie; Advincula, Maria R; Scheetz, Marc H.
Afiliação
  • McLaughlin MM; Midwestern University, Chicago College of Pharmacy, Downers Grove, IL, USA; Northwestern Memorial Hospital, Chicago, IL, USA. Electronic address: mmclau@midwestern.edu.
  • Miglis C; Midwestern University, Chicago College of Pharmacy, Downers Grove, IL, USA; Northwestern Memorial Hospital, Chicago, IL, USA.
  • Skoglund E; CHI St Luke's Health-Baylor St Luke's Medical Center, Houston, TX, USA.
  • Wagner J; University of Mississippi School of Pharmacy, Jackson, MS, USA.
  • Advincula MR; Northwestern Memorial Hospital, Chicago, IL, USA.
  • Scheetz MH; Midwestern University, Chicago College of Pharmacy, Downers Grove, IL, USA; Northwestern Memorial Hospital, Chicago, IL, USA.
J Glob Antimicrob Resist ; 13: 261-263, 2018 06.
Article em En | MEDLINE | ID: mdl-29432939

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cilastatina / Imipenem / Infecções por Bactérias Gram-Negativas / Bactérias Gram-Negativas Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cilastatina / Imipenem / Infecções por Bactérias Gram-Negativas / Bactérias Gram-Negativas Idioma: En Ano de publicação: 2018 Tipo de documento: Article